T-bet knockout prevents Helicobacter felis-induced gastric cancer

Journal of Immunology

Volumn 183, Issue 1, 2009, Pages 642-649

  Stoicov, Calin ^a   Fan, Xueli ^a   Liu, Jian Hua ^a   Bowen, Glennice ^a   Whary, Mark ^b   Kurt Jones, Evelyn ^a   Houghton, JeanMarie ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA; T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR TBX21; T-BOX TRANSCRIPTION FACTOR TBX21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; C57BL 6 MOUSE; CANCER PREVENTION; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CELL PROTECTION; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENETIC REGULATION; HELICOBACTER FELIS; HELICOBACTER INFECTION; IMMUNE RESPONSE; KNOCKOUT GENE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH CHIEF CELL; STOMACH MUCOSA LESION; STOMACH PARIETAL CELL; TH1 CELL; WILD TYPE; ADENOCARCINOMA; ANIMAL; C57BL MOUSE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MICROBIOLOGY; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; STOMACH MUCOSA; STOMACH TUMOR;

ADENOCARCINOMA; ANIMALS; FEMALE; GASTRIC MUCOSA; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER FELIS; HELICOBACTER INFECTIONS; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; STOMACH NEOPLASMS; T-BOX DOMAIN PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68949114416     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900511     Document Type: Article

References (39)

1. Parkin, D. M., E. Laara, and C. S. Muir. 1988. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int. J. Cancer. 41: 184-197.
2. Landis, S. H., T. Murray, S. Bolden, and P. A. Wingo. 1999. Cancer statistics, 1999. CA Cancer J. Clin. 49: 8-31.
3. Neugut, A. I., M. Hayek, and G. Howe. 1996. Epidemiology of gastric cancer. Semin. Oncol. 23: 281-291.
4. Chan, A. O., B. C. Wong, and S. K. Lam. 2001. Gastric cancer: past, present and future. Can. J. Gastroenterol. 15: 469-474. (Pubitemid 32755675)
5. El-Omar, E. M., M. Carrington, W. H. Chow, K. E. McColl, J. H. Bream, H. A. Young, J. Herrera, J. Lissowska, C. C. Yuan, N. Rothman, et al. 2000. Interleukin 1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402.
6. El-Omar, E. M., C. S. Rabkin, M. D. Gammon, T. L. Vaughan, H. A. Risch, J. B. Schoenberg, J. L. Stanford, S. T. Mayne, J. Goedert, W. J. Blot, et al. 2003. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124: 1193-1201.
7. Sutton, P., T. Kolesnikow, S. Danon, J. Wilson, and A. Lee. 2000. Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not γ interferon. Infect. Immun. 68: 4802-4804.
8. Eaton, K. A., M. Mefford, and T. Thevenot. 2001. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J. Immunol. 66: 7456-7461.
9. Wang, T. C., J. R. Goldenring, C. Dangler, S. Ito, A. Mueller, W. K. Jeon, T. J. Koh, and J. G. Fox. 1998. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology 14: 675-689.
10. Cai, X., J. Carlson, C. Stoicov, H. Li, T. C. Wang, and J. Houghton. 2005. Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology 128: 1937-1952.
11. Houghton, J., L. S. Macera-Bloch, L. Harrison, K. H. Kim, and R. M. Korah. 2000. Tumor necrosis factor α and interleukin 1β up-regulate gastric mucosal Fas antigen expression in Helicobacter pylori infection. Infect. Immun. 68: 1189-1195.
12. Correa, P., and J. Houghton. 2007. Carcinogenesis of Helicobacter pylori. Gastroenterology 133: 659-672.
13. Stoicov, C., M. Whary, A. B. Rogers, F. S. Lee, K. Klucevsek, H. Li, X. Cai, R. Saffari, Z. Ge, I. Khan, A. Luster, J. G. Fox, and J. Houghton. 2004. Coinfection modulates inflammatory response and clinical outcomes of Helicobacter felis and Toxoplasma gondii infection. J. Immunol. 173: 3329-3336.
14. Cui, G., J. Houghton, N. Finkel, J. Carlson, and T. C. Wang. 2003. IFN-γ infusion induces gastric atrophy, metaplasia and dysplasia in the absence of Helicobacter infection: a role for immune response in Helicobacter disease. Gastroenterology 124: A19.
15. Fox, J. G., P. Beck, C. A. Dangler, M. T. Whary, T. C. Wang, N. H. Shi, and C. Nagler-Anderson. 2000. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces Helicobacter-induced gastric atrophy. Nat. Med. 6: 536-541.
16. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
17. Wang, T. C., C. A. Dangler, D. Chen, J. R. Goldenring, T. Koh, R. Raychowdhury, R. J. Coffee, S. Ito, A. Varro, G. J. Dockray, and J. G. Fox. 2000. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 118: 36-47.
18. -ΔΔCT method. Methods 25: 402-408.
19. Houghton, J., L. Macera Bloch, M. Goldstein, S. von Hagen, and R. Korah. 2000. In vivo disruption of the Fas pathway abrogates gastric growth alterations secondary to Helicobacter infection. J. Infect. Dis. 182: 856-864.
20. Houghton, J., R. Korah, M. Condon, and K. Kim. 1999. Apoptosis in H. pylori associated gastric and duodenal ulcer disease is mediated by the Fas antigen pathway. Dig. Dis. Sci. 44: 465-478. (Pubitemid 29137953)
21. Kang, W., S. Rathinavelu, L. C. Samuelson, and J. L. Merchant. 2005. Interferon γ induction of gastric mucous neck cell hypertrophy. Lab. Invest. 85: 702-715.
22. Venkataraman, C., S. Leung, A. Salvekar, H. Mano, and U. Schindler. 1999. Repression of IL-4-induced gene expression by IFN-γ requires Stat1 activation. J. Immunol. 162: 4053-4061.
23. Dickensheets, H. L., C. Venkataraman, U. Schindler, and R. P. Donnelly. 1999. Interferons inhibit activation of STAT-6 by interleukin-4 in human monocytes by inducting SOCS 2 gene expression. Proc. Natl. Acad. Sci. USA 96: 10800-10805.
24. Aliprantis, A. O., J. Wang, J. W. Fathman, R. Lemaire, D. M. Dorfman, R. Lafyatis, and L. H. Glimcher. 2007. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proc. Natl. Acad. Sci. USA 104: 2827-2830.
25. Zavros, Y., G, Rieder, A. Ferguson, L. C. Samuelson, and J. L. Merchant. 2002. Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. Gastroenterology 122: 119-133.
26. Tan, M. P., M. Darparakis, M. Galic, J. Pedersen, M. Pearse, O. L. C. Wijburg, P. H. Janssen, and R. A. Strugnell. 2007. Chronic Helicobacter pylori infection does not significantly alter the microbiota of the murine stomach. Appl. Environ. Microbiol. 73: 1010-1013.
27. Stoicov, C., X. Cai, H. Li, K. Klucevsek, R. Saffari, and J. Houghton. 2005. Major histocompatibility complex class II inhibits Fas antigen-mediated gastric mucosal cell apoptosis through actin-dependent inhibition of receptor aggregation. Infect. Immun. 73: 6311-6321.
28. Li, H., X. Cai, X. Fan, B. Moquin, C. Stoicov, and J. Houghton. 2008. Fas Ag-FasL coupling leads to ERK1/2-mediated proliferation of gastric mucosal cells. Am. J. Physiol. 294: G263-G275.
29. Lee, S. H., H. S. Kim, S. Y. Kim, Y. S. Lee, W. S. Park, S. H. Kim, J. Y. Lee, and N. J. Yoo. 2003. Increased expression of FLIP, an inhibitor of Fas-mediated apoptosis, in stomach cancer. APMIS 111: 309-314.
30. S. C. Lim. 2003. Fas-related apoptosis in gastric adenocarcinoma. Oncol. Rep. 10: 57-63.
31. Osaki, M., S. Kase, I. Kodani, M. Watanabe, H. Adachi, and H. Ito. 2001. Expression of Fas and Fas ligand in human gastric adenomas and intestinal-type carcinomas: correlation with proliferation and apoptosis. Gastric Cancer 4: 198-205.
32. Park, W. S., R. R. Oh, Y. S. Kim, J. Y. Park, S. H. Lee, M. S. Shin, S. Y. Kim, P. J. Kim, H. K. Lee, N. Y. Yoo, and J. Y. Lee. 2001. Somatic mutations in the death domain of the Fas (Apo-1/CD95) gene in gastric cancer. J. Pathol. 193: 162-168.
33. + cells in gastritis due to Helicobacter pylori in mice. Infect. Immun. 74: 4673-4684.
34. Neurath, M. F., B. Weigmann, S. Finotto, J. Glickman, E. Nieuwenhuis, H. Iijima, A. Mizoguchi, E. Mizoguchi, J. Mudter, P. B. Galle, et al. 2002. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 95: 1129-1143.
35. Peek, R. M., Jr. 2008. Prevention of gastric cancer: when is treatment of Helicobacter pylori warranted? Ther. Adv. Gastroenterol. 1: 19.
36. Tsugane, S., and S. Sasazuki. 2007. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 10: 75-83.
37. Tu, S., G. Bhagat, G. Cui, S. Takaishi, E. A. Kurt-Jones, B. Rickman, K. S. Betz, M. Penz-Oesterreicher, O. Bjorkdahl, J. G. Fox, and T. C. Wang. 2008. Over-expression of interleukin-1β induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 14: 408-419.
38. Du, Y., A. Agnew, X. Ye, P. A. Robinson, D. Forman, and J. E. Crabtree. 2006. Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio. Microbes Infect. 8: 52-60.
39. Camargo, M. C., R. Mera, P. Correa, R. M. Peek, Jr., E. T. Fontham, K. J. Goodman, M. B. Piazuelo, L. Sicinschi, J. Zabaleta, and B. G. Schneider. 2006. Interleukin-1β and interleukin 1 receptor antagonist gene polymorphisms and gastric cancer: a meta analysis. Cancer Epidemiol. Biomarkers Prev. 15: 1674-1687.